INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 344 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2024. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $19,079,533 | +212.0% | 278,574 | +215.2% | 0.03% | +200.0% |
| Q1 2024 | $6,115,757 | +737.3% | 88,378 | +766.6% | 0.01% | +900.0% |
| Q4 2023 | $730,381 | -75.1% | 10,198 | -81.9% | 0.00% | -87.5% |
| Q3 2023 | $2,932,094 | +258.8% | 56,289 | +336.2% | 0.01% | +166.7% |
| Q2 2023 | $817,081 | -52.9% | 12,904 | -59.8% | 0.00% | -57.1% |
| Q1 2023 | $1,736,536 | +323.5% | 32,069 | +219.2% | 0.01% | +40.0% |
| Q2 2021 | $410,000 | -47.8% | 10,046 | -56.6% | 0.01% | -58.3% |
| Q1 2021 | $786,000 | -51.2% | 23,160 | -54.3% | 0.01% | -47.8% |
| Q4 2020 | $1,612,000 | +346.5% | 50,683 | +260.1% | 0.02% | +360.0% |
| Q3 2020 | $361,000 | – | 14,076 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 360,000 | $11,502,000 | 2.65% |
| Redmile Group, LLC | 610,171 | $19,495,000 | 1.60% |
| Pier Capital, LLC | 257,256 | $8,219,000 | 1.18% |
| WALL STREET ASSOCIATES | 358,857 | $11,465,000 | 1.08% |
| SENZAR ASSET MANAGEMENT, LLC | 161,300 | $5,154,000 | 0.88% |
| Rhenman & Partners Asset Management AB | 206,000 | $6,582,000 | 0.79% |
| EAM Investors, LLC | 152,389 | $4,869,000 | 0.57% |
| EDMOND DE ROTHSCHILD (SUISSE) S.A. | 50,000 | $1,598,000 | 0.51% |
| Visium Asset Management, LP | 1,051,479 | $33,595,000 | 0.48% |
| SPHERA FUNDS MANAGEMENT LTD. | 128,000 | $4,090,000 | 0.40% |